$4.04m Adjusted EBITDA Beauty Device Company - CONTRACT PENDING

United States, Florida

Asking Price: $28,926,918

Cash Flow: $4,004,056

Gross Sales: $18,849,409

Area: Global

FFE: $140,000

Inventory: $1,400,000

Real Estate: $0

Established: 2014

Request More Information

Jonathan Barak

Business Intemediary Specialist

954-596-8060

[email protected]

View Listings & Qualifications

Summary

$4.04m Adjusted EBITDA Beauty Device Company - CONTRACT PENDING

Company selling its own branded beauty devices (tech-enabled) to clients in over 60+ countries. Strong customer base including distributors and niche retailers, and can expand strategically to aesthetic service providers. The Company maintains difficult to obtain FDA 510k designations & CE certification for numerous of their products. IP protection in place in North America and Asia. - Management and principals willing to remain on-board and roll equity with correct partners - considering potential exit and partnership possibilities. - Complete dataroom readily available (post LOI). - The Company also maintains agreements with some of their largest key customers. - After years in development, 2 new products finalized and 1 in soft launch phase - with first-mover advantage. - One of the new products would be a great addition to partner with skincare product companies. - Products tested with multiple medically-backed studies proving benefits and technologies.

Detailed Information

Sub-Category: Wholesale/Dist. Businesses

County: N/A

Employees: 14 - Full-Time, 32 - Part-Time

Facilities: Offices located in North America, with sales teams in various locations

Relocatable: No

Home Based: No

Market Notes: Expected major increases to at-home home skin-care device market segment through 2025 & beyond. Large beauty companies & medical Device companies have been steadily focusing on beauty devices & beauty-tech, which has been continuing to grow in popularity.

Growth Notes: This company has grown exponentially within the first 5 years since its inception. While COVID temporarily slowed the company's growth, management has been focused on rebuilding. Sales accelerated during the 2021 holiday season and have continued to sustain, with a strong 2022 EBITDA. Outstanding new products (years in R&D) currently being launched with 1st mover advantage - major capability to drive sales, especially when partnered with certain types of companies.

Support Training: Owners & management willing to remain on-board with right partners.

Financing Terms: TBD

Reason for Selling: Considering exit and partnership possibilities.

Inventory Included: No

Is Franchise: No

Lender Prequalified: No

Absentee Owner: No

Selling Financing: No

Is FEE Included: Yes